BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van den Broek FJC, Stokkers PCF, Reitsma JB, Boltjes RPB, Ponsioen CY, Fockens P, Dekker E. Random Biopsies Taken During Colonoscopic Surveillance of Patients With Longstanding Ulcerative Colitis: Low Yield and Absence of Clinical Consequences. American Journal of Gastroenterology 2014;109:715-22. [DOI: 10.1038/ajg.2011.93] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Klinger AL, Kann BR. Endoscopy in Inflammatory Bowel Disease. Surgical Clinics of North America 2019;99:1063-82. [DOI: 10.1016/j.suc.2019.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Sengupta N, Yee E, Feuerstein JD. Colorectal Cancer Screening in Inflammatory Bowel Disease. Dig Dis Sci 2016;61:980-9. [DOI: 10.1007/s10620-015-3979-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
3 Kaltenbach T, Leite G, Soetikno R. Colonoscopy Surveillance and Management of Dysplasia in Inflammatory Bowel Disease. Curr Treat Options Gastro 2016;14:103-14. [DOI: 10.1007/s11938-016-0072-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Verdon C, Aruljothy A, Lakatos PL, Bessissow T. Endoscopic surveillance strategies for dysplasia in ulcerative colitis. Frontline Gastroenterol 2020;11:124-32. [PMID: 32133111 DOI: 10.1136/flgastro-2018-101056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Rubin DT. Why it’s time for updated U.S. colorectal cancer prevention guidelines in inflammatory bowel disease. Gastrointestinal Endoscopy 2014;80:849-51. [DOI: 10.1016/j.gie.2014.08.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Klepp P, Tollisen A, Røseth A, Cvancarova Småstuen M, Andersen SN, Vatn M, Moum BA, Brackmann S. Real-life chromoendoscopy for dysplasia surveillance in ulcerative colitis. World J Gastroenterol 2018; 24(35): 4069-4076 [PMID: 30254411 DOI: 10.3748/wjg.v24.i35.4069] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Galanopoulos M, Tsoukali E, Gkeros F, Vraka M, Karampekos G, Matzaris GJ. Screening and surveillance methods for dysplasia in inflammatory bowel disease patients: Where do we stand? World J Gastrointest Endosc 2018; 10(10): 250-258 [PMID: 30364842 DOI: 10.4253/wjge.v10.i10.250] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Gaidos JKJ, Bickston SJ. How to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease Patients: . Inflammatory Bowel Diseases 2016;22:1219-30. [DOI: 10.1097/mib.0000000000000685] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
9 Pouw RE, Bisschops R, Gecse KB, de Hertogh G, Iacucci M, Rutter M, Barret M, Biermann K, Czakó L, Hucl T, Jansen M, Savarino E, Spaander MCW, Schmidt PT, Dinis-Ribeiro M, Vieth M, van Hooft JE. Endoscopic tissue sampling - Part 2: Lower gastrointestinal tract. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2021;53:1261-73. [PMID: 34715702 DOI: 10.1055/a-1671-6336] [Reference Citation Analysis]
10 Schwegmann K, Bettenworth D, Hermann S, Faust A, Poremba C, Foell D, Schäfers M, Domagk D, Lenz P. Detection of Early Murine Colorectal Cancer by MMP-2/-9-Guided Fluorescence Endoscopy. Inflamm Bowel Dis 2016;22:82-91. [PMID: 26457379 DOI: 10.1097/MIB.0000000000000605] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
11 Manchanda S, Rizvi QUA, Singh R. Role of endoscopy in the surveillance and management of colorectal neoplasia in inflammatory bowel disease. World J Clin Cases 2019; 7(1): 1-9 [PMID: 30637247 DOI: 10.12998/wjcc.v7.i1.1] [Reference Citation Analysis]
12 Carballal S, Maisterra S, López-serrano A, Gimeno-garcía AZ, Vera MI, Marín-garbriel JC, Díaz-tasende J, Márquez L, Álvarez MA, Hernández L, De Castro L, Gordillo J, Puig I, Vega P, Bustamante-balén M, Acevedo J, Peñas B, López-cerón M, Ricart E, Cuatrecasas M, Jimeno M, Pellisé M. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD. Gut 2017;67:70-8. [DOI: 10.1136/gutjnl-2016-312332] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 11.0] [Reference Citation Analysis]
13 Saraiva S, Rosa I, Moleiro J, Pereira da Silva J, Fonseca R, Dias Pereira A. Dysplasia Surveillance in Inflammatory Bowel Disease: A Cohort Study. GE Port J Gastroenterol 2021;28:97-105. [PMID: 33791396 DOI: 10.1159/000510728] [Reference Citation Analysis]
14 Shah SC, Ten Hove JR, Castaneda D, Palmela C, Mooiweer E, Colombel JF, Harpaz N, Ullman TA, van Bodegraven AA, Jansen JM, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, Oldenburg B, Itzkowitz SH, Torres J. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2018;16:1106-1113.e3. [PMID: 29378311 DOI: 10.1016/j.cgh.2018.01.023] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
15 Naymagon S, Marion JF. Surveillance in inflammatory bowel disease: chromoendoscopy and digital mucosal enhancement. Gastrointest Endosc Clin N Am 2013;23:679-94. [PMID: 23735110 DOI: 10.1016/j.giec.2013.03.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
16 Stidham RW, Higgins PDR. Colorectal Cancer in Inflammatory Bowel Disease. Clin Colon Rectal Surg. 2018;31:168-178. [PMID: 29720903 DOI: 10.1055/s-0037-1602237] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 16.8] [Reference Citation Analysis]
17 Desai D, Desai N. Colorectal cancer surveillance in inflammatory bowel disease: A critical analysis. World J Gastrointest Endosc 2014; 6(11): 541-548 [PMID: 25400868 DOI: 10.4253/wjge.v6.i11.541] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
18 Lichtenstein GR, Picco MF, Solomon S, Bickston SJ. The use of chromoendoscopy for surveillance of inflammatory bowel disease. VideoGIE 2018;3:35-42. [PMID: 29905188 DOI: 10.1016/j.vgie.2017.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Yu JX, East JE, Kaltenbach T. Surveillance of patients with inflammatory bowel disease. Best Practice & Research Clinical Gastroenterology 2016;30:949-58. [DOI: 10.1016/j.bpg.2016.10.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
20 Ward D, Neumann A, Hendel JW, Riis LB, Tøttrup A, Jess T, Aalykke C. Danish Society for Gastroenterology and Hepatology’s clinical recommendations for colonoscopic surveillance for colorectal dysplasia and cancer in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology. [DOI: 10.1080/00365521.2021.2022191] [Reference Citation Analysis]
21 Tontini GE, Rath T, Pastorelli L, Vecchi M, Neumann H. Surveillance strategies for colitis-associated cancer: state of the art and future perspectives. Expert Review of Gastroenterology & Hepatology 2017;11:427-37. [DOI: 10.1080/17474124.2017.1297705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Laine L, Kaltenbach T, Barkun A, McQuaid KR, Subramanian V, Soetikno R;  SCENIC Guideline Development Panel. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 2015; 148: 639-651. e28. [PMID: 25702852 DOI: 10.1053/j.gastro.2015.01.031] [Cited by in Crossref: 268] [Cited by in F6Publishing: 224] [Article Influence: 38.3] [Reference Citation Analysis]
23 Mark-Christensen A, Laurberg S, Haboubi N. Dysplasia in Inflammatory Bowel Disease: Historical Review, Critical Histopathological Analysis, and Clinical Implications. Inflamm Bowel Dis 2018;24:1895-903. [PMID: 29668897 DOI: 10.1093/ibd/izy075] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
24 Tontini GE, Pastorelli L, Ishaq S, Neumann H. Advances in endoscopic imaging in ulcerative colitis. Expert Rev Gastroenterol Hepatol 2015;9:1393-405. [PMID: 26365308 DOI: 10.1586/17474124.2015.1087848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
25 Krugliak Cleveland N, Huo D, Sadiq F, Sofia MA, Marks J, Cohen RD, Hanauer SB, Turner J, Hart J, Rubin DT. Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease. Gastrointestinal Endoscopy 2018;87:1304-9. [DOI: 10.1016/j.gie.2017.12.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
26 ten Hove JR, Oldenburg B. Surveillance of long-standing colitis: the role of image-enhanced endoscopy. Best Pract Res Clin Gastroenterol 2015;29:687-97. [PMID: 26381312 DOI: 10.1016/j.bpg.2015.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Chascsa DM, Lindor KD. Cancer risk, screening and surveillance in primary sclerosing cholangitis. Minerva Gastroenterol Dietol 2019;65. [DOI: 10.23736/s1121-421x.19.02586-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
28 Karjalainen EK, Renkonen-Sinisalo L, Lepistö AH. Dysplasia in the mucosal biopsy specimen is still a warning sign of cancer in ulcerative colitis. Scand J Gastroenterol 2020;55:1019-23. [PMID: 32672485 DOI: 10.1080/00365521.2020.1794024] [Reference Citation Analysis]
29 Shergill AK, Farraye FA. Endoscopic evaluation for colon cancer and dysplasia in patients with inflammatory bowel disease. Techniques in Gastrointestinal Endoscopy 2016;18:145-51. [DOI: 10.1016/j.tgie.2016.08.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Alexandersson B, Hamad Y, Andreasson A, Rubio CA, Ando Y, Tanaka K, Ichiya T, Rezaie R, Schmidt PT. High-Definition Chromoendoscopy Superior to High-Definition White-Light Endoscopy in Surveillance of Inflammatory Bowel Diseases in a Randomized Trial. Clin Gastroenterol Hepatol 2020;18:2101-7. [PMID: 32353535 DOI: 10.1016/j.cgh.2020.04.049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
31 Moran CP, Neary B, Doherty GA. Endoscopic evaluation in diagnosis and management of inflammatory bowel disease. World J Gastrointest Endosc 2016; 8(20): 723-732 [PMID: 28042386 DOI: 10.4253/wjge.v8.i20.723] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
32 Marion JF, Sands BE. The SCENIC consensus statement on surveillance and management of dysplasia in inflammatory bowel disease: praise and words of caution. Gastroenterology. 2015;148:462-467. [PMID: 25702851 DOI: 10.1053/j.gastro.2015.01.029] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
33 Shi JL, Lv YH, Huang J, Huang X, Liu Y. Patients with inflammatory bowel disease and post-inflammatory polyps have an increased risk of colorectal neoplasia: A meta-analysis. World J Clin Cases 2022; 10(3): 966-984 [DOI: 10.12998/wjcc.v10.i3.966] [Reference Citation Analysis]
34 Iskandar HN, Dhere T, Farraye FA. Ulcerative Colitis: Update on Medical Management. Curr Gastroenterol Rep. 2015;17:44. [PMID: 26386686 DOI: 10.1007/s11894-015-0466-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
35 Parian A, Lazarev M. Who and how to screen for cancer in at-risk inflammatory bowel disease patients. Expert Rev Gastroenterol Hepatol 2015;9:731-46. [PMID: 25592672 DOI: 10.1586/17474124.2015.1003208] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
36 Huang LC, Merchea A. Dysplasia and Cancer in Inflammatory Bowel Disease. Surgical Clinics of North America 2017;97:627-39. [DOI: 10.1016/j.suc.2017.01.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
37 Mooiweer E, van der Meulen-de Jong AE, Ponsioen CY, Fidder HH, Siersema PD, Dekker E, Oldenburg B. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study. Am J Gastroenterol. 2015;110:1014-1021. [PMID: 25823770 DOI: 10.1038/ajg.2015.63] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 11.0] [Reference Citation Analysis]
38 Beg S, Wilson A, Ragunath K. The use of optical imaging techniques in the gastrointestinal tract. Frontline Gastroenterol 2016;7:207-15. [PMID: 27429735 DOI: 10.1136/flgastro-2015-100563] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
39 Clarke WT, Feuerstein JD. Updates in colorectal cancer screening in inflammatory bowel disease. Current Opinion in Gastroenterology 2018;34:208-16. [DOI: 10.1097/mog.0000000000000448] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
40 Buchner AM, Lichtenstein GR. Evaluation and Detection of Dysplasia in IBD: the Role of Chromoendoscopy and Enhanced Imaging Techniques. Curr Treat Options Gastro 2016;14:73-82. [DOI: 10.1007/s11938-016-0078-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
41 Laine L, Kaltenbach T, Barkun A, McQuaid KR, Subramanian V, Soetikno R; SCENIC Guideline Development Panel. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015;81:489-501.e26. [PMID: 25708752 DOI: 10.1016/j.gie.2014.12.009] [Cited by in Crossref: 198] [Cited by in F6Publishing: 162] [Article Influence: 28.3] [Reference Citation Analysis]
42 Bessissow T, Dulai PS, Restellini S, Landry T, Bisschops R, Murad MH, Singh S. Comparison of Endoscopic Dysplasia Detection Techniques in Patients With Ulcerative Colitis: A Systematic Review and Network Meta-analysis. Inflamm Bowel Dis. 2018;. [PMID: 29846600 DOI: 10.1093/ibd/izy188] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
43 Chiu K, Riddell RH, Schaeffer DF. DALM, rest in peace: a pathologist’s perspective on dysplasia in inflammatory bowel disease in the post-DALM era. Mod Pathol 2018;31:1180-90. [DOI: 10.1038/s41379-018-0068-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
44 Leifeld L, Rogler G, Stallmach A, Schmidt C, Zuber-jerger I, Hartmann F, Plauth M, Drabik A, Hofstädter F, Dienes HP, Kruis W, Büttner R, Löser H, Drebber U, Dignass A, Terjung B, Sauerbruch T, Schreiber S, Lanyi B, Pfuetzer R, Morgenstern J, Böhm S, Böcker U, Rupf A, Appenroth B, Biecker E, Walldorf J. White-Light or Narrow-Band Imaging Colonoscopy in Surveillance of Ulcerative Colitis: A Prospective Multicenter Study. Clinical Gastroenterology and Hepatology 2015;13:1776-1781.e1. [DOI: 10.1016/j.cgh.2015.04.172] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
45 Limdi JK, Farraye FA. An Update on Surveillance in Ulcerative Colitis. Curr Gastroenterol Rep. 2018;20:7. [PMID: 29516293 DOI: 10.1007/s11894-018-0612-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
46 Goetz M. Endoscopic Surveillance in Inflammatory Bowel Disease. Visc Med. 2018;34:66-71. [PMID: 29594172 DOI: 10.1159/000485019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
47 Toiyama Y, Araki T, Tanaka K, Mohri Y, Kusunoki M. Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer. In: Kusunoki M, editor. Colitis-Associated Cancer. Tokyo: Springer Japan; 2016. pp. 85-105. [DOI: 10.1007/978-4-431-55522-3_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
48 Chan WPW, Tan YB, Shim HH, Kaltenbach T, Soetikno R. Practice pattern variability among gastroenterologists in colorectal cancer surveillance and management of colorectal dysplasia in inflammatory bowel disease. J Dig Dis 2021;22:463-72. [PMID: 34173325 DOI: 10.1111/1751-2980.13031] [Reference Citation Analysis]
49 Megna B, Weiss J, Ley D, Saha S, Pfau P, Grimes I, Li Z, Caldera F. Clear liquid diet before bowel preparation predicts successful chromoendoscopy in patients with inflammatory bowel disease. Gastrointest Endosc 2019;89:373-379.e2. [PMID: 30339950 DOI: 10.1016/j.gie.2018.09.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
50 Beintaris I, Rutter M. Advanced imaging in colonoscopy: contemporary approach to dysplasia surveillance in inflammatory bowel disease. Frontline Gastroenterol 2016;7:308-15. [PMID: 28839872 DOI: 10.1136/flgastro-2016-100735] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
51 Axelrad JE, Shah SC. Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era. Therap Adv Gastroenterol 2020;13:1756284820920779. [PMID: 32523622 DOI: 10.1177/1756284820920779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 van der Laan JJH, van der Waaij AM, Gabriëls RY, Festen EAM, Dijkstra G, Nagengast WB. Endoscopic imaging in inflammatory bowel disease: current developments and emerging strategies. Expert Rev Gastroenterol Hepatol 2021;15:115-26. [PMID: 33094654 DOI: 10.1080/17474124.2021.1840352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
53 Kim KO, Chiorean MV. Advanced neoplasia detection using chromoendoscopy and white light colonoscopy for surveillance in patients with inflammatory bowel disease. Intest Res 2020;18:438-46. [PMID: 33131232 DOI: 10.5217/ir.2019.00090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
54 Mücke MM, Bettenworth D, Geyer C, Schwegmann K, Poremba C, Schäfers M, Domagk D, Höltke C, Lenz P. Targeting Mucosal Endothelin-A-Receptor Expression by Fluorescence Endoscopy is Feasible to Detect and Characterize Colitis-Associated Cancer in Mice. Inflammatory Bowel Diseases 2018;24:111-22. [DOI: 10.1093/ibd/izx032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
55 Lewis JD, Cross RK, Long M, Singh S, Herfarth H, Weiss A, Buchner A. High Degree of Practice Variability in Colonic Dysplasia Surveillance for Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izab347. [PMID: 35022777 DOI: 10.1093/ibd/izab347] [Reference Citation Analysis]
56 Kim ER, Chang DK. Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis. World J Gastroenterol 2014; 20(29): 9872-9881 [PMID: 25110418 DOI: 10.3748/wjg.v20.i29.9872] [Cited by in CrossRef: 196] [Cited by in F6Publishing: 177] [Article Influence: 24.5] [Reference Citation Analysis]
57 Sivanathan V, Tontini GE, Möhler M, Galle PR, Neumann H. Advanced endoscopic imaging for diagnosis of inflammatory bowel diseases: Present and future perspectives. Dig Endosc 2018;30:441-8. [PMID: 29360261 DOI: 10.1111/den.13023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
58 Hata K, Anzai H, Ikeuchi H, Futami K, Fukushima K, Sugita A, Uchino M, Higashi D, Itabashi M, Watanabe K, Koganei K, Araki T, Kimura H, Mizushima T, Ueda T, Ishihara S, Suzuki Y; on behalf of the Research Group for Intractable Inflammatory Bowel Disease of the Ministry of Health, Labour and Welfare of Japan (RGIBD). Surveillance Colonoscopy for Ulcerative Colitis-Associated Colorectal Cancer Offers Better Overall Survival in Real-World Surgically Resected Cases. Am J Gastroenterol 2019;114:483-9. [DOI: 10.14309/ajg.0000000000000117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
59 Coelho-Prabhu N, Bruining DH, Faubion WA, Kane SV, Kisiel JB, Papadakis KA, Pardi DS, Raffals LE, Schroeder KW, Tremaine WJ, Fruth K, Harmsen WS, Loftus EV. A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and Chromoendoscopy. Inflamm Bowel Dis 2021;27:594-602. [PMID: 32529198 DOI: 10.1093/ibd/izaa146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 East JE. Colonoscopic Cancer Surveillance in Inflammatory Bowel Disease: What’s New Beyond Random Biopsy? Clin Endosc. 2012;45:274-277. [PMID: 22977816 DOI: 10.5946/ce.2012.45.3.274] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
61 Bartel MJ, Picco MF, Wallace MB. Chromocolonoscopy. Gastrointest Endosc Clin N Am. 2015;25:243-260. [PMID: 25839685 DOI: 10.1016/j.giec.2014.11.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
62 Shah SA, Rubin DT, Farraye FA. Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease. Curr Gastroenterol Rep. 2014;16:407. [PMID: 25113042 DOI: 10.1007/s11894-014-0407-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
63 Shukla R, Salem M, Hou JK. Use and barriers to chromoendoscopy for dysplasia surveillance in inflammatory bowel disease. World J Gastrointest Endosc 2017; 9(8): 359-367 [PMID: 28874956 DOI: 10.4253/wjge.v9.i8.359] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
64 Watanabe T, Ajioka Y, Mitsuyama K, Watanabe K, Hanai H, Nakase H, Kunisaki R, Matsuda K, Iwakiri R, Hida N, Tanaka S, Takeuchi Y, Ohtsuka K, Murakami K, Kobayashi K, Iwao Y, Nagahori M, Iizuka B, Hata K, Igarashi M, Hirata I, Kudo SE, Matsumoto T, Ueno F, Watanabe G, Ikegami M, Ito Y, Oba K, Inoue E, Tomotsugu N, Takebayashi T, Sugihara K, Suzuki Y, Watanabe M, Hibi T. Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer. Gastroenterology. 2016;151:1122-1130. [PMID: 27523980 DOI: 10.1053/j.gastro.2016.08.002] [Cited by in Crossref: 95] [Cited by in F6Publishing: 85] [Article Influence: 15.8] [Reference Citation Analysis]
65 Ayoola R, Mohanty M, Lee JE, Sifuentes H. The Role of Chromoendoscopy and Enhanced Imaging Techniques in Inflammatory Bowel Disease Colorectal Cancer Colonoscopy Surveillance. In: Sridhar S, Wu GY, editors. Diagnostic and Therapeutic Procedures in Gastroenterology. Cham: Springer International Publishing; 2018. pp. 331-7. [DOI: 10.1007/978-3-319-62993-3_25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Moussata D, Allez M, Cazals-Hatem D, Treton X, Laharie D, Reimund JM, Bertheau P, Bourreille A, Lavergne-Slove A, Brixi H, Branche J, Gornet JM, Stefanescu C, Moreau J, Marteau P, Pelletier AL, Carbonnel F, Seksik P, Simon M, Flejou JF, Colombel JF, Charlois AL, Roblin X, Nancey S, Bouhnik Y, Berger F, Flourie B, the GETAID. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut. 2018;67:616-624. [PMID: 28115492 DOI: 10.1136/gutjnl-2016-311892] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
67 Freire P, Figueiredo P, Cardoso R, Donato MM, Ferreira M, Mendes S, Silva MR, Cipriano A, Ferreira AM, Vasconcelos H. Surveillance in ulcerative colitis: is chromoendoscopy-guided endomicroscopy always better than conventional colonoscopy? A randomized trial. Inflamm Bowel Dis. 2014;20:2038-2045. [PMID: 25185683 DOI: 10.1097/mib.0000000000000176] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 2.9] [Reference Citation Analysis]
68 Mooiweer E, Oldenburg B. The Debate Continues Over the Best Method of Endoscopic Surveillance for Colorectal Cancer in Patients With Colitis. Clin Gastroenterol Hepatol. 2015;13:1782-1784. [PMID: 26122766 DOI: 10.1016/j.cgh.2015.06.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
69 Pant C, Olyaee MS, Rastogi A. Advanced imaging and therapeutic endoscopy. Techniques in Gastrointestinal Endoscopy 2017;19:151-8. [DOI: 10.1016/j.tgie.2017.08.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
70 Hu AB, Burke KE, Kochar B, Ananthakrishnan AN. Yield of Random Biopsies During Colonoscopies in Inflammatory Bowel Disease Patients Undergoing Dysplasia Surveillance. Inflamm Bowel Dis 2021;27:779-86. [PMID: 32812048 DOI: 10.1093/ibd/izaa205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
71 Aladrén BS, González-Lama Y, García-Alvarado M, Sierra M, Barrio JA, Vicente VP, Hernández L, Velayos B, Garcia LA, Relea L, Suarez P, Atienza R, Vásquez M, Fernández-Salazar L, Muñoz F; GEICYL (group of inflammatory bowel disease of Castilla y León) . Even non-experts identify non-dysplastic lesions in inflammatory bowel disease via chromoendoscopy: results of a screening program in real-life. Endosc Int Open 2019;7:E743-50. [PMID: 31157291 DOI: 10.1055/a-0839-4514] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Dlugosz A, Barakat AM, Björkström NK, Öst Å, Bergquist A. Diagnostic yield of endomicroscopy for dysplasia in primary sclerosing cholangitis associated inflammatory bowel disease: a feasibility study. Endosc Int Open 2016;4:E901-11. [PMID: 27540581 DOI: 10.1055/s-0042-111203] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
73 Clarke WT, Feuerstein JD. Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments. World J Gastroenterol 2019; 25(30): 4148-4157 [PMID: 31435169 DOI: 10.3748/wjg.v25.i30.4148] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 31] [Article Influence: 12.7] [Reference Citation Analysis]
74 Singh K, Al Khoury A, Kurti Z, Gonczi L, Reinglas J, Verdon C, Kohen R, Bessissow T, Afif W, Wild G, Seidman E, Bitton A, Lakatos PL. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance. J Crohns Colitis. 2019;13:1343-1350. [PMID: 30918959 DOI: 10.1093/ecco-jcc/jjz066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
75 Deepak P, Hanson GJ, Fletcher JG, Tremaine WJ, Pardi DS, Kisiel JB, Schroeder KW, Wong Kee Song LM, Harmsen WS, Loftus EV, Bruining DH. Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy. Gastrointestinal Endoscopy 2016;83:1005-12. [DOI: 10.1016/j.gie.2015.09.021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
76 Marion JF, Waye JD, Israel Y, Present DH, Suprun M, Bodian C, Harpaz N, Chapman M, Itzkowitz S, Abreu MT. Chromoendoscopy Is More Effective Than Standard Colonoscopy in Detecting Dysplasia During Long-term Surveillance of Patients With Colitis. Clin Gastroenterol Hepatol. 2016;14:713-719. [PMID: 26656297 DOI: 10.1016/j.cgh.2015.11.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
77 Ten Hove JR, Mooiweer E, Dekker E, van der Meulen-de Jong AE, Offerhaus GJ, Ponsioen CY, Siersema PD, Oldenburg B. Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2017;15:222-228.e2. [PMID: 27613257 DOI: 10.1016/j.cgh.2016.08.035] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
78 Toiyama Y, Okugawa Y, Kondo S, Okita Y, Araki T, Kusunoki K, Uchino M, Ikeuchi H, Hirota S, Mitsui A, Takehana K, Umezawa T, Kusunoki M. Comprehensive analysis identifying aberrant DNA methylation in rectal mucosa from ulcerative colitis patients with neoplasia. Oncotarget 2018;9:33149-59. [PMID: 30237858 DOI: 10.18632/oncotarget.26032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
79 Shah SC, Itzkowitz SH. Management of Inflammatory Bowel Disease-Associated Dysplasia in the Modern Era. Gastrointest Endosc Clin N Am 2019;29:531-48. [PMID: 31078251 DOI: 10.1016/j.giec.2019.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
80 Goetz M. Confocal Laser Endomicroscopy: Applications in Clinical and Translational Science—A Comprehensive Review. ISRN Pathology 2012;2012:1-13. [DOI: 10.5402/2012/387145] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
81 Fung BM, Lindor KD, Tabibian JH. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies. World J Gastroenterol 2019; 25(6): 659-671 [PMID: 30783370 DOI: 10.3748/wjg.v25.i6.659] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 26] [Article Influence: 13.7] [Reference Citation Analysis]
82 American Society for Gastrointestinal Endoscopy Standards of Practice Committee. , Shergill AK, Lightdale JR, Bruining DH, Acosta RD, Chandrasekhara V, Chathadi KV, Decker GA, Early DS, Evans JA, Fanelli RD, Fisher DA, Fonkalsrud L, Foley K, Hwang JH, Jue TL, Khashab MA, Muthusamy VR, Pasha SF, Saltzman JR, Sharaf R, Cash BD, DeWitt JM. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc 2015; 81: 1101-21. e1-13. [PMID: 25800660 DOI: 10.1016/j.gie.2014.10.030] [Cited by in Crossref: 172] [Cited by in F6Publishing: 152] [Article Influence: 24.6] [Reference Citation Analysis]